Science
Mechanism of Action
This biomimetic peptide is fully homologous to human skin's native collagen sequence. Its mechanism involves a dual action: it actively inhibits enzymes, specifically metalloproteinases (MMPs), which are responsible for degrading the extracellular matrix (ECM) and compromising the dermal-epidermal junction (DEJ). Simultaneously, it stimulates the synthesis of vital ECM components, particularly collagen types I and III, thereby increasing overall collagen content in the skin, strengthening its structure, and boosting elasticity and hydration.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Specific optimal pH for PENTAPEPTIDE-69's stability was not explicitly detailed. However, peptides generally achieve optimal stability in buffer solutions with a pH range of 3-5, which helps mitigate deamidation and oxidation while protecting disulfide bridges. Formulators should be mindful of potential incompatibilities with other excipients, as these can lead to aggregation, precipitation, or degradation, ultimately compromising the peptide's efficacy and safety profile.
Safety
Safety Profile
Dedicated safety assessments from regulatory bodies such as CIR, SCCS, or FDA for PENTAPEPTIDE-69 (SH-Polypeptide-69) are not readily available in the current research. General safety profiles of related peptides, like Palmitoyl Pentapeptide-4, typically indicate good skin tolerance and a low potential for irritation or sensitization.
Your Skin
Skin Compatibility
Our Assessment
Verdict
PENTAPEPTIDE-69 is a valuable biomimetic peptide offering a dual mechanism to robustly stimulate collagen synthesis and inhibit its degradation, presenting significant potential for enhancing skin structure, elasticity, and hydration.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources